SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001501134-23-000077
Filing Date
2023-09-22
Accepted
2023-09-22 17:02:38
Documents
15
Period of Report
2023-09-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvta-20230920.htm   iXBRL 8-K 30040
2 EX-99.1 nyselistingnoticepressrele.htm EX-99.1 7641
6 invitaelogoaa.jpg GRAPHIC 36208
7 nvta-20230920_g1.jpg GRAPHIC 36208
  Complete submission text file 0001501134-23-000077.txt   308407

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvta-20230920.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvta-20230920_lab.xml EX-101.LAB 24139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvta-20230920_pre.xml EX-101.PRE 12508
9 EXTRACTED XBRL INSTANCE DOCUMENT nvta-20230920_htm.xml XML 2713
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 231272366
SIC: 8071 Services-Medical Laboratories